Abstract
Purpose
Despite the development of modern chemotherapeutics and target-specific drugs as well as improved surgical techniques, prognosis of metastatic breast cancer remains poor. Only a small number of selected patients will be eligible for liver resection and/or alternative metastatic ablation. Data on prognostic factors for patients with surgically resectable liver metastases of breast cancer are scarce at present.
Methods
From 1997 to 2010, 50 patients with hepatic metastases of breast cancer have undergone laparotomy with the intention to undergo a curative liver resection at our institution. Data from these patients were collected in a prospectively maintained standardized liver resection data base.
Results
Liver resection was performed in 34 patients. Resection margins were clear in 21 cases (R0). Nine patients lived for more than 60 months after liver resection. The observed 5-year survival rate was 21 % for all 50 patients, 28 % for resected patients and 38 % after R0-resection. On univariate analysis, survival rates of the resected patients were statistically significantly influenced by R-classification, age, extrahepatic tumour at the time of liver resection, size of metastases and HER2 expression of liver metastases. Multivariate analysis revealed absence of HER2 expression, presence of extrahepatic tumour and patient’s age ≥50 years as independent factors of poor prognosis.
Conclusions
Breast cancer patients younger than 50 years with technically resectable hepatic metastases, minimal extrahepatic tumour and positive HER2 expression appear to be suitable candidates for liver resection with curative intent. An aggressive multi-disciplinary management of those patients including surgical treatment may improve long-term survival.
Similar content being viewed by others
References
Abdalla EK (2011) Resection of colorectal liver metastases. J Gastrointest Surg 15(3):416–419. doi:10.1007/s11605-011-1429-6
Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897–907. doi:10.1097/01.sla.0000246847.02058.1b discussion 907-898
Arena E, Ferrero S (2004) Surgical treatment of liver metastases from breast cancer. Minerva Chir 59(1):7–15
Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM (2008) Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 247(5):732–738. doi:10.1097/SLA.0b013e3181656d32
Cai GX, Cai SJ (2012) Multi-modality treatment of colorectal liver metastases. World J Gastroenterol 18(1):16–24. doi:10.3748/wjg.v18.i1.16
Carlini M, Lonardo MT, Carboni F, Petric M, Vitucci C, Santoro R, Lepiane P, Ettorre GM, Santoro E (2002) Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology 49(48):1597–1601
Chua TC, Saxena A, Liauw W, Chu F, Morris DL (2011) Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer 47(15):2282–2290. doi:10.1016/j.ejca.2011.06.024
Elias D, Di Pietroantonio D (2006) Surgery for liver metastases from breast cancer. HPB (Oxford) 8(2):97–99. doi:10.1080/13651820500471871
Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185(2):158–164
Fang L, Barekati Z, Zhang B, Liu Z, Zhong X (2011) Targeted therapy in breast cancer: what’s new? Swiss Med Wkly 141:w13231. doi:10.4414/smw.2011.13231
Fields RC, Jeffe DB, Trinkaus K, Zhang Q, Arthur C, Aft R, Dietz JR, Eberlein TJ, Gillanders WE, Margenthaler JA (2007) Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 14(12):3345–3351. doi:10.1245/s10434-007-9527-0
Hoffmann K, Franz C, Hinz U, Schirmacher P, Herfarth C, Eichbaum M, Buchler MW, Schemmer P (2010) Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol 17(6):1546–1554. doi:10.1245/s10434-010-0931-5
Houssami N, Macaskill P, Balleine RL, Bilous M, Pegram MD (2011) HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Res Treat 129(3):659–674. doi:10.1007/s10549-011-1632-x
Illing R, Gillams A (2010) Radiofrequency ablation in the treatment of breast cancer liver metastases. Clin Oncol (R Coll Radiol) 22(9):781–784. doi:10.1016/j.clon.2010.08.004
Iwata H (2011) Future treatment strategies for metastatic breast cancer: curable or incurable? Breast Cancer. doi:10.1007/s12282-011-0267-4
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107
Jensen JD, Knoop A, Ewertz M, Laenkholm AV (2012) ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. Breast Cancer Res Treat 132(2):511–521. doi:10.1007/s10549-011-1610-3
Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E (2008) Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol 19(12):2012–2019. doi:10.1093/annonc/mdn424
Marme F, Schneeweiss A (2012) Personalized therapy in breast cancer. Onkologie 35(Suppl 1):28–33. doi:10.1159/000334973
Martinez SR, Young SE, Giuliano AE, Bilchik AJ (2006) The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 191(2):281–283. doi:10.1016/j.amjsurg.2005.08.030
O’Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R, Wall D, John TG, Welsh F, Rees M (2008) Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15(1):207–218. doi:10.1245/s10434-007-9649-4
Pentheroudakis G, Fountzilas G, Bafaloukos D, Koutsoukou V, Pectasides D, Skarlos D, Samantas E, Kalofonos HP, Gogas H, Pavlidis N (2006) Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 97(3):237–244. doi:10.1007/s10549-005-9117-4
Pocard M, Pouillart P, Asselain B, Salmon R (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 26(2):155–159. doi:10.1053/ejso.1999.0761
Raab R, Nussbaum KT, Behrend M, Weimann A (1998) Liver metastases of breast cancer: results of liver resection. Anticancer Res 18(3C):2231–2233
Ruiterkamp J, Ernst MF (2011) The role of surgery in metastatic breast cancer. Eur J Cancer 47(Suppl 3):S6–22. doi:10.1016/S0959-8049(11)70142-3
Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC (2009) Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 35(11):1146–1151. doi:10.1016/j.ejso.2009.03.012
Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, Makuuchi M (2005) Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 29(4):524–527. doi:10.1007/s00268-004-7688-6
Settmacher U, Dittmar Y, Knosel T, Schone U, Heise M, Jandt K, Altendorf-Hofmann AK (2011) Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis 26(8):967–981. doi:10.1007/s00384-011-1195-7
Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, Meric F, Hortobagyi GN (2003) A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8(3):241–251
Thelen A, Benckert C, Jonas S, Lopez-Hanninen E, Sehouli J, Neumann U, Rudolph B, Neuhaus P (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97(1):25–29. doi:10.1002/jso.20911
Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, Curley SA, Ellis LM, Roh MS, Vauthey JN (2004) Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11(9):869–874. doi:10.1245/ASO.2004.01.007
Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, Meyer T (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12(10):778–785. doi:10.1245/ASO.2005.11.018
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dittmar, Y., Altendorf-Hofmann, A., Schüle, S. et al. Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature. J Cancer Res Clin Oncol 139, 1317–1325 (2013). https://doi.org/10.1007/s00432-013-1440-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1440-2